Physician profile
Margaret Parsons
NPI 1609952860
$2,687.14
in general payments reported to CMS, 2019-2025
21 companies · $525 in 2025
The $525 reported for 2025 was less than what a typical Procedural Dermatology provider received nationally (typical 2025 total: $599).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $146 · 2021: $175 · 2022: $707 · 2023: $440 · 2024: $387 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,351.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $868.18 | 2019-2025 | |
| Lilly USA, LLC | $299.33 | 2021-2023 | Taltz, Olumiant |
| Genzyme Corporation | $228.97 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $227.17 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $204.68 | 2021-2025 | Dupixent |
| Incyte Corporation | $169.49 | 2022 | |
| Kyowa Kirin, INC. | $118.38 | 2019 | |
| Janssen Scientific Affairs, LLC | $100.56 | 2019 | |
| Amgen INC. | $80.65 | 2020-2024 | Otezla |
| Janssen Biotech, INC. | $79.39 | 2019-2025 | Tremfya |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.05 | 2019-2024 | Siliq |
| Galderma Laboratories, L.P. | $37.24 | 2024 | |
| Dermavant Sciences, INC. | $36.26 | 2022-2023 | Vtama |
| Ucb, INC. | $35.46 | 2024-2025 | Bimzelx |
| Strata Skin Sciences, INC. | $34.69 | 2025 | Xtrac |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries LP | $28.20 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $25.06 | 2024 | Sotyktu |
| Dermira, INC. | $24.84 | 2020 | |
| Organon LLC | $19.03 | 2025 | Vtama |
| Almirall LLC | $17.01 | 2022 | |
| Sun Pharmaceutical Industries INC. | $13.50 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Parsons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.